1987 related articles for article (PubMed ID: 33119871)
21. Effect of Stromal Cells in Tumor Microenvironment on Metastasis Initiation.
Guo S; Deng CX
Int J Biol Sci; 2018; 14(14):2083-2093. PubMed ID: 30585271
[TBL] [Abstract][Full Text] [Related]
22. Nitric oxide and interactions with reactive oxygen species in the development of melanoma, breast, and colon cancer: A redox signaling perspective.
Monteiro HP; Rodrigues EG; Amorim Reis AKC; Longo LS; Ogata FT; Moretti AIS; da Costa PE; Teodoro ACS; Toledo MS; Stern A
Nitric Oxide; 2019 Aug; 89():1-13. PubMed ID: 31009708
[TBL] [Abstract][Full Text] [Related]
23. Mesenchymal Stem Cells in the Tumor Microenvironment.
Atiya H; Frisbie L; Pressimone C; Coffman L
Adv Exp Med Biol; 2020; 1234():31-42. PubMed ID: 32040853
[TBL] [Abstract][Full Text] [Related]
24. DNA methylation in the tumor microenvironment.
Zhang MW; Fujiwara K; Che X; Zheng S; Zheng L
J Zhejiang Univ Sci B; 2017 May; 18(5):365-372. PubMed ID: 28471108
[TBL] [Abstract][Full Text] [Related]
25. How to Hit Mesenchymal Stromal Cells and Make the Tumor Microenvironment Immunostimulant Rather Than Immunosuppressive.
Poggi A; Varesano S; Zocchi MR
Front Immunol; 2018; 9():262. PubMed ID: 29515580
[TBL] [Abstract][Full Text] [Related]
26. Insights into the role of components of the tumor microenvironment in oral carcinoma call for new therapeutic approaches.
Salo T; Vered M; Bello IO; Nyberg P; Bitu CC; Zlotogorski Hurvitz A; Dayan D
Exp Cell Res; 2014 Jul; 325(2):58-64. PubMed ID: 24462456
[TBL] [Abstract][Full Text] [Related]
27. Metabolism within the tumor microenvironment and its implication on cancer progression: An ongoing therapeutic target.
Ocaña MC; Martínez-Poveda B; Quesada AR; Medina MÁ
Med Res Rev; 2019 Jan; 39(1):70-113. PubMed ID: 29785785
[TBL] [Abstract][Full Text] [Related]
28. Interaction of tumor‑associated macrophages with stromal and immune components in solid tumors: Research progress (Review).
Kazakova A; Sudarskikh T; Kovalev O; Kzhyshkowska J; Larionova I
Int J Oncol; 2023 Feb; 62(2):. PubMed ID: 36660926
[TBL] [Abstract][Full Text] [Related]
29. The Roles of CD38 and CD157 in the Solid Tumor Microenvironment and Cancer Immunotherapy.
Wo YJ; Gan ASP; Lim X; Tay ISY; Lim S; Lim JCT; Yeong JPS
Cells; 2019 Dec; 9(1):. PubMed ID: 31861847
[TBL] [Abstract][Full Text] [Related]
30. Immunosuppressive cells in tumor immune escape and metastasis.
Liu Y; Cao X
J Mol Med (Berl); 2016 May; 94(5):509-22. PubMed ID: 26689709
[TBL] [Abstract][Full Text] [Related]
31. Targeting Tumor Microenvironment for Cancer Therapy.
Roma-Rodrigues C; Mendes R; Baptista PV; Fernandes AR
Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30781344
[TBL] [Abstract][Full Text] [Related]
32. Latest Advances in Targeting the Tumor Microenvironment for Tumor Suppression.
Laplagne C; Domagala M; Le Naour A; Quemerais C; Hamel D; Fournié JJ; Couderc B; Bousquet C; Ferrand A; Poupot M
Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31547627
[TBL] [Abstract][Full Text] [Related]
33. Normalization of the tumor microvasculature based on targeting and modulation of the tumor microenvironment.
Li Z; Ning F; Wang C; Yu H; Ma Q; Sun Y
Nanoscale; 2021 Oct; 13(41):17254-17271. PubMed ID: 34651623
[TBL] [Abstract][Full Text] [Related]
34. The tumor microenvironment as driver of stemness and therapeutic resistance in breast cancer: New challenges and therapeutic opportunities.
Mehraj U; Ganai RA; Macha MA; Hamid A; Zargar MA; Bhat AA; Nasser MW; Haris M; Batra SK; Alshehri B; Al-Baradie RS; Mir MA; Wani NA
Cell Oncol (Dordr); 2021 Dec; 44(6):1209-1229. PubMed ID: 34528143
[TBL] [Abstract][Full Text] [Related]
35. The Antitumor Cytotoxic Response: If the Killer Cells Play the Music, the Microenvironmental Hypoxia Plays the Tune.
Chouaib S
Crit Rev Immunol; 2020; 40(2):157-166. PubMed ID: 32749093
[TBL] [Abstract][Full Text] [Related]
36. Modulation of the tumor microenvironment (TME) by melatonin.
Mu Q; Najafi M
Eur J Pharmacol; 2021 Sep; 907():174365. PubMed ID: 34302814
[TBL] [Abstract][Full Text] [Related]
37. Exosomal miRNAs in tumor microenvironment.
Tan S; Xia L; Yi P; Han Y; Tang L; Pan Q; Tian Y; Rao S; Oyang L; Liang J; Lin J; Su M; Shi Y; Cao D; Zhou Y; Liao Q
J Exp Clin Cancer Res; 2020 Apr; 39(1):67. PubMed ID: 32299469
[TBL] [Abstract][Full Text] [Related]
38. The Role of Tumor Associated Macrophages (TAMs) in Cancer Progression, Chemoresistance, Angiogenesis and Metastasis - Current Status.
Dallavalasa S; Beeraka NM; Basavaraju CG; Tulimilli SV; Sadhu SP; Rajesh K; Aliev G; Madhunapantula SV
Curr Med Chem; 2021; 28(39):8203-8236. PubMed ID: 34303328
[TBL] [Abstract][Full Text] [Related]
39. Targeting the tumor microenvironment: removing obstruction to anticancer immune responses and immunotherapy.
Pitt JM; Marabelle A; Eggermont A; Soria JC; Kroemer G; Zitvogel L
Ann Oncol; 2016 Aug; 27(8):1482-92. PubMed ID: 27069014
[TBL] [Abstract][Full Text] [Related]
40. Nanomedicine-based cancer immunotherapies developed by reprogramming tumor-associated macrophages.
Li X; Guo X; Ling J; Tang Z; Huang G; He L; Chen T
Nanoscale; 2021 Mar; 13(9):4705-4727. PubMed ID: 33625411
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
